{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:02:15Z","timestamp":1790521335302,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lpm.2021.104091","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:32:25Z","timestamp":1635381145000},"page":"104091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cushing's disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Amandine","family":"Ferriere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.lpm.2021.104091_bib0001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0004","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The Epidemiology of Pituitary Adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0005","doi-asserted-by":"crossref","first-page":"dgaa409","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0006","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0007","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0008","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","article-title":"Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms","volume":"41","author":"Srirangam Nadhamuni","year":"2020","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0010","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing's syndrome","volume":"173","author":"Ferrau","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.lpm.2021.104091_bib0012","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"The lancet Diabetes & endocrinology"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0014","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0015","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1210\/jc.2016-1673","article-title":"A probabilistic model for Cushing's syndrome screening in at-risk populations: a prospective multicenter study","volume":"101","author":"Leon-Justel","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0016","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2018-00005","article-title":"Pituitary diseases and bone","volume":"39","author":"Mazziotti","year":"2018","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cen.13743","article-title":"Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score","volume":"89","author":"Vinolas","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0018","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.lpm.2021.104091_bib0019","first-page":"445","article-title":"Pros and cons of screening for occult Cushing syndrome","volume":"7","author":"Tabarin","year":"2011","journal-title":"Nat Rev"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0020","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-19-0666","article-title":"Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis","volume":"182","author":"van Hulsteijn","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0022","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0023","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2021.104091_bib0024","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0025","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of cushing Syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0026","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-16-0946","article-title":"Diagnosis of endocrine disease: differentiation of pathologic\/neoplastic hypercortisolism (Cushing's syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing's disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0028","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2013-4262","article-title":"Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome","volume":"99","author":"Elias","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0029","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","article-title":"Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome","volume":"157","author":"Kidambi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ecl.2014.10.005","article-title":"Cushing syndrome: update on testing","volume":"44","author":"Raff","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.lpm.2021.104091_bib0031","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1210\/js.2019-00186","article-title":"Bedtime salivary cortisol and cortisone by LC-MS\/MS in healthy adult subjects: evaluation of sampling time","volume":"3","author":"Raff","year":"2019","journal-title":"Je Endocr Soc"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0032","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(01)02496-X","article-title":"The start of the quiescent period of cortisol remains phase locked to the melatonin onset despite circadian phase alterations in humans working the night schedule","volume":"318","author":"Weibel","year":"2002","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0033","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1210\/jc.2017-02020","article-title":"Variability of late-night salivary cortisol in Cushing disease: a prospective study","volume":"103","author":"Sandouk","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0034","doi-asserted-by":"crossref","first-page":"bvaa107","DOI":"10.1210\/jendso\/bvaa107","article-title":"Prospective evaluation of late-night salivary cortisol and cortisone by EIA and LC-MS\/MS in suspected Cushing syndrome","volume":"4","author":"Kannankeril","year":"2020","journal-title":"J Endocr Soc"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0035","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1210\/jc.2006-2829","article-title":"Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing's disease from pseudo-Cushing's Syndrome","volume":"92","author":"Gatta","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0036","first-page":"1163","article-title":"A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states","volume":"83","author":"Papanicolaou","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0037","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2265.2006.02717.x","article-title":"The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states","volume":"66","author":"Pecori Giraldi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0038","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1530\/EJE-20-1127","article-title":"Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome","volume":"184","author":"Brossaud","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0039","doi-asserted-by":"crossref","first-page":"dgaa564","DOI":"10.1210\/clinem\/dgaa564","article-title":"Human corticotropin-releasing hormone tests: 10 years of real-life experience in pituitary and adrenal disease","volume":"105","author":"Ceccato","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-10-0962","article-title":"Assessment of ACTH assay variability: a multicenter study","volume":"164","author":"Pecori Giraldi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0041","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1530\/EJE-18-0007","article-title":"Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome","volume":"178","author":"Vassiliadi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0042","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0043","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-17-1071","article-title":"investigators of the M-GRS. Significant prevalence of NR3C1 mutations in incidentally discovered bilateral adrenal hyperplasia: results of the French MUTA-GR Study","volume":"178","author":"Vitellius","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0044","first-page":"1780","article-title":"Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"82","author":"Aron","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.78.2.8106630","article-title":"A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"78","author":"Dichek","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0046","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-14-0912","article-title":"ACTH after 15\u00a0min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test","volume":"173","author":"Ritzel","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0047","first-page":"1640","article-title":"Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome","volume":"87","author":"Newell-Price","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0048","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2003-030510","article-title":"Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome","volume":"88","author":"Isidori","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0049","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2019-00333","article-title":"Why we should still treat by neurosurgery patients with Cushing's disease and a normal or inconclusive pituitary MRI","volume":"105","author":"Cristante","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11102-020-01066-8","article-title":"Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis","volume":"23","author":"Stroud","year":"2020","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0051","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12020-016-1038-y","article-title":"Pituitary magnetic resonance imaging in Cushing's disease","volume":"55","author":"Vitale","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0052","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease","volume":"98","author":"Wind","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.lpm.2021.104091_bib0053","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa493","article-title":"Is it time for a new approach to the differential diagnosis of ACTH-dependent Cushing syndrome?","volume":"105","author":"Nieman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0054","doi-asserted-by":"crossref","first-page":"M107","DOI":"10.1530\/EJE-15-0616","article-title":"A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome","volume":"173","author":"Koulouri","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0055","doi-asserted-by":"crossref","first-page":"e1816","DOI":"10.1210\/clinem\/dgaa755","article-title":"Molecular imaging targeting corticotropin releasing hormone receptor for corticotropinoma: a changing paradigm","volume":"106","author":"Walia","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0056","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2014.11.FOCUS14766","article-title":"The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian society for endocrinology, Italian society for neurosurgery, and Italian society for neuroradiology","volume":"38","author":"Pecori Giraldi","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"9","key":"10.1016\/j.lpm.2021.104091_bib0057","first-page":"3401","article-title":"One transient neurological complication (sixth nerve palsy) in 166 consecutive bilateral inferior petrosal sinus sampling for the etiological diagnosis of ACTH-dependent Cushing's syndrome","volume":"84","author":"Lefournier","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0058","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2002-020374","article-title":"Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage","volume":"88","author":"Lefournier","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0059","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2265.2004.02115.x","article-title":"Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing's syndrome","volume":"61","author":"Liu","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.lpm.2021.104091_bib0060","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2021.104091_bib0061","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4158\/EP171787.OR","article-title":"Biochemical control during long-term follow-up of 230 adult patients with Cushing disease: a multicenter retrospective study","volume":"23","author":"Geer","year":"2017","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0062","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0997","article-title":"Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN","volume":"178","author":"Valassi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0063","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1530\/EJE-14-0883","article-title":"Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence","volume":"172","author":"Petersenn","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0064","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12020-020-02432-z","article-title":"Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment","volume":"70","author":"Braun","year":"2020","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.lpm.2021.104091_bib0066","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1210\/jc.2003-031908","article-title":"Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas","volume":"89","author":"Salenave","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104091_bib0067","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fendo.2019.00740","article-title":"Hypercortisolemia recurrence in Cushing's disease; a diagnostic challenge","volume":"10","author":"Hinojosa-Amaya","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0068","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0069","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-19-0770","article-title":"Persistent cortisol response to desmopressin predicts recurrence of Cushing's disease in patients with post-operative corticotropic insufficiency","volume":"182","author":"Cambos","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/cen.12534","article-title":"Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery","volume":"82","author":"Danet-Lamasou","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0071","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4158\/EP161380.OR","article-title":"Postsurgical recurrent Cushing disease: clinical benefit of early intervention in patients with normal urinary free cortisol","volume":"22","author":"Carroll","year":"2016","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0072","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3171\/2016.1.JNS152119","article-title":"Cushing's disease: pathobiology, diagnosis, and management","volume":"126","author":"Lonser","year":"2017","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0073","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ecl.2018.01.002","article-title":"Outcomes of pituitary radiation for Cushing's disease","volume":"47","author":"Ironside","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0074","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2017-01385","article-title":"Stereotactic radiosurgery for Cushing disease: results of an international, multicenter study","volume":"102","author":"Mehta","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jc.2016-3402","article-title":"Radiotherapy especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary\/sellar lesions","volume":"102","author":"Burman","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0076","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-15-0541","article-title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","volume":"23","author":"Guerin","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0077","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ecl.2020.05.004","article-title":"Nelson's syndrome: an update","volume":"49","author":"Fountas","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0078","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","article-title":"Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome","volume":"92","author":"Assie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0079","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-20-0352","article-title":"Endocrinology in the time of covid-19: management of Cushing's syndrome","volume":"183","author":"Newell-Price","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.lpm.2021.104091_bib0080","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0081","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(17)30326-1","article-title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","volume":"6","author":"Lacroix","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0082","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-16-0662","article-title":"Cabergoline for Cushing's disease: a large retrospective multicenter study","volume":"176","author":"Ferriere","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0083","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1530\/EJE-14-1014","article-title":"Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome","volume":"172","author":"Daniel","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0084","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.lpm.2021.104091_bib0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-17-0886","article-title":"Hepatic safety of ketoconazole in Cushing's syndrome: results of a compassionate use programme in France","volume":"178","author":"Young","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2021.104091_bib0086","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2011.011014","article-title":"Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11beta-hydroxylase inhibitor metyrapone","volume":"48","author":"Monaghan","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0087","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0088","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.lpm.2021.104091_bib0089","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","article-title":"Osilodrostat, a potent oral 11beta-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0091","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0092","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-20-0380","article-title":"Etomidate infusion at low doses is an effective and safe treatment for severe Cushing's syndrome outside intensive care","volume":"183","author":"Constantinescu","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0093","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104091_bib0094","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-015-0059-5","article-title":"Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension","volume":"15","author":"Fein","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.lpm.2021.104091_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.662865","article-title":"Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with cushing syndrome: results from a prospective, open-label phase 2 study","volume":"12","author":"Pivonello","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0096","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-14-0913","article-title":"Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole","volume":"172","author":"Corcuff","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.lpm.2021.104091_bib0097","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenicky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0098","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104091_bib0099","first-page":"1022","article-title":"Excess morbidity persists in patients with Cushing's disease during long-term remission: a Swedish nationwide study","volume":"98","author":"Papakokkinou","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11102-018-0897-z","article-title":"Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis","volume":"21","author":"Broersen","year":"2018","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.lpm.2021.104091_bib0101","first-page":"5325","article-title":"Improvement but no normalization of quality of life and cognitive functioning after treatment of Cushing syndrome","volume":"104","author":"Broersen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104091_bib0102","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fendo.2019.00862","article-title":"Quality of life in patients with Cushing's disease","volume":"10","author":"Santos","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104091_bib0103","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis","volume":"172","author":"van Haalen","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.lpm.2021.104091_bib0104","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104091_bib0105","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/EJE-15-0013","article-title":"Management of endocrine disease: paediatric Cushing's disease","volume":"173","author":"Storr","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104091_bib0106","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1530\/EJE-17-1058","article-title":"Management of endocrine disease: management of Cushing's syndrome during pregnancy: solved and unsolved questions","volume":"178","author":"Brue","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104091_bib0107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12020-016-1117-0","article-title":"Cushing's syndrome and pregnancy outcomes: a systematic review of published cases","volume":"55","author":"Caimari","year":"2017","journal-title":"Endocrine"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:47Z","timestamp":1760105327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0755498221000282"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104091","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cushing's disease","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104091"}}